One Additional Inch of Rainfall from Ground-Based Rain Enhancement Worth $44 Million Annually to 37 Texas Counties, Texas A&M Analysis Finds
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million
Rain Enhancement Technologies Introduces Industry-First Guaranteed 10% Precipitation Enhancement
Rain Enhancement Technologies Reports Consistent Snowpack Enhancement Across Three-Month Winter Operations in Utah
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program
Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange
Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange
Levi & Korsinsky, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Rain Oncology Inc.
Rain Enhancement Technologies Appoints David Sylvester, CFO of Steelcase, to Board of Directors
Rain Enhancement Technologies Reports Early Positive Indications From First Two U.S. Installations
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
Enlivex Announces $212,000,000 Private Placement to Initiate World's First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board
Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities
Rain Enhancement Technologies Launches First U.S. Installation with Colorado Permit Approval
Rain Enhancement Technologies Holdco, Inc. Regains Compliance with Nasdaq Listing Requirements
Rain Enhancement Technologies Exhibits at Premier WMO Scientific Conference, Showcases Ionization Research Advancements
Rain Enhancement Technologies Reports Promising Results from Australia Fog Mitigation Pilot, Plans Expanded US Testing
Rain Enhancement Technologies Strengthens Strategic Leadership with Quantum Physics Pioneer and Corporate Governance Expert
Rain Enhancement Technologies Assembles World-Class Technical Advisory Board to Advance Weather Enhancement Innovation
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. RECEIVES AND APPEALS NASDAQ DELISTING NOTICE
Rain Enhancement Technologies Announces Fog Mitigation Pilot in Australia
Rain Enhancement Technologies Strengthens Board of Directors with Appointment of Industry Veterans Bob Reardon and Marc Peperzak
Rain Enhancement Technologies Announces Appointment of Scott Morris as Senior Technical Advisor
Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer
Pathos AI Completes Acquisition of Rain Oncology
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
3 Top Penny Stocks to Buy According To Insiders In October
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
RAIN Investors Have Opportunity to Lead Rain Oncology Inc. Securities Fraud Lawsuit
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc.(RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline
RAIN Investors Have Opportunity to Lead Rain Oncology Inc. Securities Fraud Lawsuit
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN